The CHU and the Centre François Baclesse of Caen, have joined forces for the creation of a tumor library of Lower Normandy. It will retain cancer cells from which researchers can source their supplies. We are here at its inauguration.
Cancers can be treated with oral therapies. They allow patients, accompanied by a rigorous medical follow-up, to be treated at home. Let’s discover here the testimony of two patients who benefit from this kind of treatment. Interviews with Olivia Belanger, pharmacist and Professor Xavier Quantin, medical oncologist at the Regional Cancer Institute of Montpellier (ICM).
The Georges Pompidou Hospital in Paris has opened a pilot support care unit. These supportive care are treatments for cancer patients. Interviews with patients, by Florian Scotte, from the support care department, who details the different types of treatments in question and Marie-Laure Allouis, bio-aesthetic nurse.
En Bourgogne, les médecins libéraux ont décidé de publier une charte des "droits et des devoirs des patients". Ils entendent répondre à la hausse des incivilités telles que les retards et les annulations de rendez-vous. Le document est affiché dans les salles d'attente. Ici, un médecin généraliste, Emmanuel Debost, puis le président du Collectif interassociatif sur la santé, Yann Lecomte, témoignent.
Une étude de l'Union régionale des professionnels de santé montre une forte augmentation des oublis des rendez-vous chez le médecin. Du temps gâché qui pourrait être utilisé par d'autres patients. Deux médecins, le Dr Luc Refaber, pédiatre pneumologue et le Dr Jean-Michel Klein, ORL, coordinateur de l'étude, donnent leur avis sur le sujet.
Tous les patients ne respectent pas leurs rendez-vous médicaux. Oublis et annulations de dernières minutes sont courants. Dans son cabinet, un médecin témoigne des désagréments occasionnés par ces pratiques. Interviewé sur le sujet, un couple estime qu'il s'agit-là d'un manque de respect.
De plus en plus de patients annulent leurs rendez-vous au dernier moment, sans même prévenir leur médecin. Ce comportement a de lourdes conséquences sur l'organisation des soins et prive de rendez-vous d'autres malades. Témoignages ici du Dr Philippe Moisescot, ophtalmologue à Levallois-Perret et de son assistante médicale, tous deux affectés par ce manque de respect.
Visit of the Pierre and Marie Curie Institute, whose staff conducts research on cancer control. Explanations on the functioning of the institute alternate with illustrations and photos of Pierre and Marie Curie.
Interviews with doctors and patients at the Gustave Roussy cancer centre in Villejuif. They’re responding to a TV show about cancer. Interviews with Renée GELLEE, patient of the center, Professor Marcel HAYAT, Gustave Roussy Institute, Doctor Thomas TURSZ, Gustave Roussy Institute.
Report devoted to the means implemented to fight against cancer. Several centres have been opened to detect, treat and investigate the causes of cancer. Animals are used as guinea pigs to advance the fight against cancer. High-tech devices are used to understand the mysteries of this disease.
The Antoine Lacassagne Centre in Nice celebrates its 50 years of existence, 50 years in the service of the fight against cancer and the management of patients. On February 4, World Cancer Day, focus on this Nice institution that over the years has continued to evolve and still intends to develop new projects.
The Paoli Calmettes Institute in Marseille is one of the 5 immunotherapy centres in France. Its officials have just made an assessment of their action and in particular of the use of a new substance, interlukine 2 which has high dose stimulates the immune system of the patient.
[Source France 3 Régions]: In Rennes, the Eugène Marquis Centre, dedicated to the fight against cancer, is distinguished by unparalleled results in the treatment of certain liver cancers. This innovative technology, which consists of injecting radioactive microbeads, is however still reimbursed in France. At present, it is the Eugène Marquis Centre and the manufacturer who take charge of the extra cost. The Eugène Marquis Centre has been using this cutting-edge technology regularly for 6 years. 200 patients from all over France were treated. Their inoperable liver cancer usually leaves them with little life expectancy and few therapeutic options. This radioembolization treatment consists of injecting radioactive glass microbeads as close as possible to the tumor. For this, the radiologist introduces a catheter through the femoral artery of the patient to the liver. The second phase of the intervention is to send the microbeads. In principle, a single injection is sufficient for treatment. Thanks to this treatment, nearly one cancer in 4 becomes operable. The survival time of patients increases to 24 months compared to 8 months with conventional chemotherapy. These results are due in particular to a very personalized support. When his liver cancer was diagnosed 3 years ago, Marcel Goupil had only 6 months to live. Now in remission, he is a grateful patient. The cost of treatment is 20,000 euros and is not covered by the health insurance. Health authorities review the claim.
100,000 people die each year from cancer. A hundred doctors came together to try to develop a national project and a comprehensive policy to combat cancer.
Report devoted to the new goals of the National Cancer League. Interview with its president, Henri PUJOL, who explains that the next objective is to put the patient at the heart of the healing process by involving and informing him more. It is also necessary to educate the public, especially women, to be screened regularly in order to detect cancers as soon as possible, which improves the chances of recovery.
Report devoted to the end of the mission of Professors Mayer and Pommateau, of the Léon Bérard Center, who had gone to South America to exchange with doctors on the fight against cancer.
[Source France 3 Régions]: Lung cancer is one of the most common and also one of the deadliest. In some patients, the combination of chemotherapy and immunotherapy, although effective, does not work. At the Georges François Leclerc centre in Dijon, an Inserm team is studying resistance to chemotherapy of tumour cells to modify their mechanisms. Research that earned him at the end of June an endowment of 75,000 euros by the Amgen Foundation to accelerate his work and find the treatment that will improve the chances of healing patients. The first human clinical trials could begin in 2022. Hope for the sick. Lung cancer causes more than 30,000 deaths each year.
Researchers at the Becquerel Centre in Rouen have highlighted the ability of a molecule to make cancer cells receptive to therapies. This discovery could open up prospects in the treatment of leukaemia. Animal testing could begin soon. For 20 years researchers have been working on the subject, today the laboratory of the Becquerel center is the only one in France to know how to cut this molecule. The next step is to show that this part of the molecule is able to penetrate the bone marrow and if accumulate in sufficient quantity.
[Source France 3 Régions]: Toulouse at the forefront of the fight and research against cancer... New example with this world premiere realized at the oncopole... A revolutionary treatment for melanoma... It is actually to add an anti-inflammatory to the treatment to increase its effectiveness tenfold... Explanations
The INA Galaxy 
